BRPI0920838A2 - composto de tiazolil-pirazolopirimidina como intermediários sintéticos e processos sintéticos relacionados - Google Patents

composto de tiazolil-pirazolopirimidina como intermediários sintéticos e processos sintéticos relacionados

Info

Publication number
BRPI0920838A2
BRPI0920838A2 BRPI0920838A BRPI0920838A BRPI0920838A2 BR PI0920838 A2 BRPI0920838 A2 BR PI0920838A2 BR PI0920838 A BRPI0920838 A BR PI0920838A BR PI0920838 A BRPI0920838 A BR PI0920838A BR PI0920838 A2 BRPI0920838 A2 BR PI0920838A2
Authority
BR
Brazil
Prior art keywords
synthetic
thiazolyl
pyrazolopyrimidine compound
processes
intermediates
Prior art date
Application number
BRPI0920838A
Other languages
English (en)
Inventor
Robert Rizzo John
Krishan Vaid Radhe
Kumar Boini Satish
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of BRPI0920838A2 publication Critical patent/BRPI0920838A2/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/36—Opioid-abuse
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
BRPI0920838A 2008-10-02 2009-09-29 composto de tiazolil-pirazolopirimidina como intermediários sintéticos e processos sintéticos relacionados BRPI0920838A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US10215308P 2008-10-02 2008-10-02
PCT/US2009/058722 WO2010039678A1 (en) 2008-10-02 2009-09-29 Thiazolyl-pyrazolopyrimidine compounds as synthetic intermediates and related synthetic processes

Publications (1)

Publication Number Publication Date
BRPI0920838A2 true BRPI0920838A2 (pt) 2018-10-16

Family

ID=41507435

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0920838A BRPI0920838A2 (pt) 2008-10-02 2009-09-29 composto de tiazolil-pirazolopirimidina como intermediários sintéticos e processos sintéticos relacionados

Country Status (21)

Country Link
US (1) US8563718B2 (pt)
EP (1) EP2350079B1 (pt)
JP (1) JP5524221B2 (pt)
KR (1) KR101357392B1 (pt)
CN (1) CN102171212A (pt)
AR (1) AR073708A1 (pt)
AU (1) AU2009298757B2 (pt)
BR (1) BRPI0920838A2 (pt)
CA (1) CA2739422C (pt)
CY (1) CY1113499T1 (pt)
DK (1) DK2350079T3 (pt)
EA (1) EA018807B1 (pt)
ES (1) ES2397509T3 (pt)
HR (1) HRP20120961T1 (pt)
IL (1) IL211292A (pt)
MX (1) MX2011003529A (pt)
PL (1) PL2350079T3 (pt)
PT (1) PT2350079E (pt)
SI (1) SI2350079T1 (pt)
TW (1) TWI432435B (pt)
WO (1) WO2010039678A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250022913A (ko) 2017-08-14 2025-02-17 스프루스 바이오사이언시스 인코포레이티드 코티코트로핀 방출 인자 수용체 길항제
MX2019015318A (es) * 2017-08-14 2020-07-20 Spruce Biosciences Inc Antagonistas del receptor del factor liberador de corticotropina.
CN112423747A (zh) 2018-04-27 2021-02-26 云杉生物科学公司 用于治疗睾丸肾上腺残余瘤和卵巢肾上腺残余瘤的方法
MX2023001688A (es) 2020-08-12 2023-02-22 Spruce Biosciences Inc Metodos y composiciones para tratar el sindrome de ovario poliquistico.
US11708372B2 (en) 2021-11-19 2023-07-25 Spruce Biosciences, Inc. Crystalline composition of tildacerfont and methods of use and preparation thereof

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0644762B1 (en) * 1992-06-10 1997-12-17 Fujisawa Pharmaceutical Co., Ltd. Pyrazolopyridine compounds for the treatment of anemia
UA96458C2 (ru) * 2006-09-20 2011-11-10 Эли Лилли Энд Компани Тиазолпиразолопиримидиновые соединения как антагонисты рецептора crf1
US8952207B2 (en) 2007-09-11 2015-02-10 The University Of Houston System Copper-catalyzed C—H bond arylation

Also Published As

Publication number Publication date
TWI432435B (zh) 2014-04-01
KR101357392B1 (ko) 2014-02-03
AU2009298757B2 (en) 2013-08-01
MX2011003529A (es) 2011-04-21
EA018807B1 (ru) 2013-10-30
WO2010039678A1 (en) 2010-04-08
US8563718B2 (en) 2013-10-22
TW201018692A (en) 2010-05-16
US20110166345A1 (en) 2011-07-07
AR073708A1 (es) 2010-11-24
PL2350079T3 (pl) 2013-03-29
EP2350079A1 (en) 2011-08-03
CY1113499T1 (el) 2016-06-22
IL211292A (en) 2013-06-27
CA2739422A1 (en) 2010-04-08
KR20110063513A (ko) 2011-06-10
PT2350079E (pt) 2012-12-20
SI2350079T1 (sl) 2013-02-28
CA2739422C (en) 2013-03-12
CN102171212A (zh) 2011-08-31
DK2350079T3 (da) 2012-12-17
JP2012504626A (ja) 2012-02-23
ES2397509T3 (es) 2013-03-07
HRP20120961T1 (hr) 2012-12-31
JP5524221B2 (ja) 2014-06-18
EA201170526A1 (ru) 2011-10-31
EP2350079B1 (en) 2012-11-14
IL211292A0 (en) 2011-04-28
AU2009298757A1 (en) 2010-04-08

Similar Documents

Publication Publication Date Title
BRPI1010197A2 (pt) métodos e compostos de pirazolopirimidina jak
UY3955Q (es) Carrocería
BRPI0919596A2 (pt) veículo
EP2239184A4 (en) HOOD STRUCTURE FOR VEHICLE
BRPI0919695A2 (pt) proporcionando resultados de pesquisa
BRPI0920450A2 (pt) Pirrolobenzodiazepinas
BRPI0906764A2 (pt) Processos
EP2439128A4 (en) VEHICLE
BRPI0912778A2 (pt) composto de amida
BRPI1005525A2 (pt) compostos de azaazuleno
EP2529998A4 (en) COOLER HOOD CONSTRUCTION FOR A VEHICLE
DK2269432T3 (da) Landbrugskøretøj
ATE547159T1 (de) Fahrzeug
EP2413005A4 (en) earth mover
EP2284538A4 (en) Biosensor
BRPI0919597A2 (pt) manípulo de veículo
BRPI0906888A2 (pt) derivado de fenilacetamida
EP2280284A4 (en) Biosensor
BRPI0914098A2 (pt) biosensor
FR2934751B1 (fr) Tondeuse de type autoportee
BRPI1010706A2 (pt) veículo
EP2290293A4 (en) EXTRACTOR OF COOKING FUME
BRPI0911393A2 (pt) composto de 5-hidroxipirimidina-4-carboxamida
BRPI0922936A2 (pt) Combinações de composto de enaminocarbonila/espécies benéficas
EP2402349A4 (en) TRICYCLIC PYRAZOLPYRIMIDINE DERIVATIVES

Legal Events

Date Code Title Description
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]

Free format text: REFERENTE AS 7A, 8A E 9A ANUIDADES.

B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]

Free format text: EM VIRTUDE DO ARQUIVAMENTO PUBLICADO NA RPI 2495 DE 30-10-2018 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDO O ARQUIVAMENTO DO PEDIDO DE PATENTE, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.